  
  
G/TBT/N/EU/929  
29 September 2022  
(22-7309) Page: 1/2 
Committee on Technical Barriers to Trade  Original:  English  
 
  
NOTIFICATION  
The following notification is being circulated in accordance with Article 10.6  
 
1. Notifying Member:  EUROPEAN UNION  
If applicable, name of local government involved (Article 3.2 and 7.2):   
2. Agency responsible:   
European Commission  
Name and address (including telephone and fax numbers , email and website 
addresses, if available) of agency or authority designated to handle comments 
regarding the notification shall be indicated if different from above:   
European Comm ission,  
EU-TBT Enquiry Point,  
Fax: +(32) 2 299 80 43,  
E-mail: grow-eu-tbt@ec.europa.eu  
Website: http://ec.europa.eu/growth/tools -databases/tbt/en/  
3. Notified under Article 2.9.2 [X], 2.10.1 [  ], 5.6.2 [  ], 5.7.1 [  ], 3.2 [  ], 7.2 [  ], 
other :  
4. Products covered (HS or CCCN where applicable, otherwise national tariff 
heading. ICS numbers may be provided in addition, where applicable):  Biocidal 
products  
5. Title, number of pages and language(s) of the notified document:  Draft 
Commission Implementi ng Decision not approving 2,2 -Dibromo -2-cyanoacetamide 
(DBNPA) as an existing active substance for use in biocidal products of product -type 4 in 
accordance with Regulation (EU) No 528/2012 of the European Parliament and of the 
Council; (5 page(s), in Engli sh) 
6. Description of content:  This draft Commission Implementing Decision does not approve 
2,2-Dibromo -2-cyanoacetamide (DBNPA) as an active substance for use in biocidal 
products of product -type 4.  
DBNPA has endocrine disrupting properties that may caus e adverse effects in humans 
and the environment (non -target organisms) in accordance with the criteria laid down in 
Commission Delegated Regulation (EU) 2017/2100. DBNPA therefore meets the exclusion 
criteria set out in Article 5(1), point (d), of Regulati on (EU) No 528/2012. None of the 
derogation criteria under Article 5(2) of the BPR are considered met, alternatives are 
available for its use in biocidal products of product -type 4.  
It is therefore appropriate not to approve DBNPA for use in biocidal produ cts of product -
type 4.  
7. Objective and rationale, including the nature of urgent problems where 
applicable:  Harmonisation of the EU market on biocidal products; Protection of human 
health or safety; Protection of the environment  G/TBT/N/EU/929  
 
- 2 - 
 
  8. Relevant documents:   
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 
2012 concerning the making available on the market and use of biocidal products (OJ L 
167, 27.6.2012, p. 1.). Available in all EU languages.  
EUR-Lex - 32012R0528 - EN - EUR-Lex (europa.eu)  
Commission Delegated Regulation (EU) 2017/2100 of 4 September 2017 setting out 
scientific criteria for the determination of endocrine -disrupting properties pursuant to 
Regulation (EU) No 528/2012 of the European Parliament and Council (OJ L 301, 
17.11.2017, p. 1)  
EUR-Lex - 32017R2100 - EN - EUR-Lex (europa.eu)  
The opinions of the European Chemicals Agency can be found on its website  
http://echa.europa.eu/regulations/biocidal -products -regulation/approval -of-active -
substances/bpc -opinions -on-active -substance -approval  
9. Proposed date of adoption:  December 2022  
Proposed date of entry into force:  20 days from publication in the Official Journal of 
the EU (Application 12 months after adoption)  
10. Final date for comments:  60 days from notification  
11. Texts available from:  National enquiry point [ ] or address, telephone and fax 
numbers and email and website addresses, if available , of other body:   
European Commission,  
EU-TBT Enquiry Point,  
Fax: + (32) 2 299 80 43,  
E-mail: grow-eu-tbt@ec.europa.eu  
The text is available on the EU -TBT Website : http://ec.europa.eu/growth/tools -
databases/tbt/en/  
https://members.wto.org/crnattachments/2022/TBT/EEC/22_6634_00_e.pdf  
 